Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder

Objectives Rapid eye movement (REM) sleep behavior disorder (RBD) is the most specific marker of prodromal alpha‐synucleinopathies. We sought to delineate the baseline clinical characteristics of RBD and evaluate risk stratification models. Methods Clinical assessments were performed in 171 RBD, 296 control, and 119 untreated Parkinson's (PD) participants. Putative risk measures were assessed as predictors of prodromal neurodegeneration, and Movement Disorders Society (MDS) criteria for prodromal PD were applied. Participants were screened for common leucine‐rich repeat kinase 2 (LRRK2)/glucocerebrosidase gene (GBA) gene mutations. Results Compared to controls, participants with RBD had higher rates of solvent exposure, head injury, smoking, obesity, and antidepressant use. GBA mutations were more common in RBD, but no LRRK2 mutations were found. RBD participants performed significantly worse than controls on Unified Parkinson's Disease Rating Scale (UPDRS)‐III, timed “get‐up‐and‐go”, Flamingo test, Sniffin Sticks, and cognitive tests and had worse measures of constipation, quality of life (QOL), and orthostatic hypotension. For all these measures except UPDRS‐III, RBD and PD participants were equally impaired. Depression, anxiety, and apathy were worse in RBD compared to PD participants. Stratification of people with RBD according to antidepressant use, obesity, and age altered the odds ratio (OR) of hyposmia compared to controls from 3.4 to 45.5. 74% (95% confidence interval [CI] 66%, 80%) of RBD participants met the MDS criteria for probable prodromal Parkinson's compared to 0.3% (95% CI 0.009%, 2%) of controls. Conclusions RBD are impaired across a range of clinical measures consistent with prodromal PD and suggestive of a more severe nonmotor subtype. Clinical risk stratification has the potential to select higher risk patients for neuroprotective interventions.

[1]  Klaus Seppi,et al.  Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community , 2016, Movement disorders : official journal of the Movement Disorder Society.

[2]  K. Jellinger,et al.  Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis , 2016, Neurology.

[3]  R. Postuma,et al.  Screening for prodromal Parkinson's disease in the general community: a sleep-based approach. , 2016, Sleep medicine.

[4]  Shuohua Chen,et al.  Risk factors for probable REM sleep behavior disorder , 2016, Neurology.

[5]  Joan Santamaria,et al.  Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions , 2016, The Lancet Neurology.

[6]  E. Tolosa,et al.  Absence of LRRK2 mutations in a cohort of patients with idiopathic REM sleep behavior disorder , 2016, Neurology.

[7]  R. Camicioli,et al.  Parkinson Disease: The Relationship Between Non-motor Symptoms and Motor Phenotype , 2015, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[8]  Günther Deuschl,et al.  MDS research criteria for prodromal Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[9]  W. Chung,et al.  Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. , 2015, Brain : a journal of neurology.

[10]  A. Desautels,et al.  GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder , 2015, Annals of clinical and translational neurology.

[11]  E. Tolosa,et al.  Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers , 2015, PloS one.

[12]  W. Oertel,et al.  Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study , 2015, Annals of neurology.

[13]  R. Postuma,et al.  Parkinson risk in idiopathic REM sleep behavior disorder , 2015, Neurology.

[14]  A. Schapira,et al.  Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort. , 2015, JAMA neurology.

[15]  M. Kumar,et al.  Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson’s Disease , 2014, Cell.

[16]  J. Molinuevo,et al.  Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients , 2014, PloS one.

[17]  Klaus P. Ebmeier,et al.  Predictors of cognitive impairment in an early stage Parkinson’s disease cohort , 2014, Movement disorders : official journal of the Movement Disorder Society.

[18]  Yoav Ben-Shlomo,et al.  REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  R. Postuma,et al.  Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? , 2013, Sleep.

[20]  Carlos H Schenck,et al.  Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. , 2013, Sleep medicine.

[21]  B. Boeve,et al.  Treatment outcomes in REM sleep behavior disorder. , 2013, Sleep medicine.

[22]  W. Oertel,et al.  Environmental risk factors for REM sleep behavior disorder , 2012, Neurology.

[23]  A. Schapira,et al.  A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  V. Mok,et al.  Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[25]  D. Berg,et al.  GBA-associated PD presents with nonmotor characteristics , 2011, Neurology.

[26]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[27]  Y. Wing,et al.  REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[28]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[29]  Geert Mayer,et al.  The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument , 2007, Movement disorders : official journal of the Movement Disorder Society.

[30]  A. Mackay-Sim,et al.  Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects , 2007, European Archives of Oto-Rhino-Laryngology.

[31]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[32]  R. Chervin Epworth sleepiness scale? , 2003, Sleep medicine.

[33]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[34]  B. Boeve,et al.  Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. , 2000, Brain : a journal of neurology.

[35]  Jeffrey A. Johnson,et al.  Comparison of the EQ-5D and SF-12 in an adult US sample , 1998, Quality of Life Research.

[36]  A. Beck,et al.  Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. , 1996, Journal of personality assessment.

[37]  R. Hébert,et al.  The Purdue Pegboard Test: normative data for people aged 60 and over. , 1995, Disability and rehabilitation.

[38]  D. Greenblatt,et al.  The International Classification of Sleep Disorders , 1992 .

[39]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[40]  M. Hamilton,et al.  The Leeds Scales for the Self-Assessment of Anxiety and Depression , 1976, British Journal of Psychiatry.

[41]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[42]  J. Santamaria,et al.  The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: A Study in 203 Consecutive Patients. , 2016, Sleep.